Mobile

A study of the safety, tolerability, and efficacy of GS-9620 in combination with Tenofovir Disoproxil Fumarate (TDF) in adults with chronic hepatitis B (CHB) infection who are currently not being trea...

Mise à jour : Il y a 5 ans
Référence : EUCTR2015-002017-30

A study of the safety, tolerability, and efficacy of GS-9620 in combination with Tenofovir Disoproxil Fumarate (TDF) in adults with chronic hepatitis B (CHB) infection who are currently not being treated

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

- To evaluate the safety and tolerability of GS-9620 in adult subjects with chronic hepatitis B (CHB) infection who are currently not being treated -To evaluate the efficacy of GS-9620 as measured by the change from Baseline (BL) to Week 24 in serum Hepatitis B surface Antigen (HBsAg log10 IU/mL) levels

Critère d'inclusion

  • Treatment of Subjects with Chronic Hepatitis B and who are currently not on Treatment

Liens